IL1B and bladder transitional cell carcinoma: Although BLCA has been associated with inflammation, the precise molecular pathways involved in inflammation-related BLCA remain largely uncertain, although it was suggested that inflammatory cytokines (i.e., IL-1, IL-6, TNFα) could drive bladder carcinogenesis and suppress the anti-tumor immune response [54].